Not Yet RecruitingPhase 3Phase 4ACTRN12626000082303

Topical Dutasteride on Male pattern hairloss.

Efficacy and safety of topical dutasteride solution in Androgenetic alopecia.

Sponsor

Eric Song - Reskin Medical

Enrollment

20 participants

Start Date

Jan 26, 2026

Study Type

Interventional

Conditions

androgenetic alopecia

Summary

There is some evidence Topical application of dutasteride solution is effective in treating androgenetic alopecia. Local pilot study aims to study the efficacy of topical dutasteride solution to validate this claim.

Eligibility

Sex: MalesMin Age: 18 YearssMax Age: 60 Yearss

Inclusion Criteria1

Norwood-Hamilton grade 3-5 Androgenetic alopecia.

Exclusion Criteria4

Female
Spouses of pregnant patient
Other types of alopecia
Other medical treatment for hairloss within last 6 months

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Topical 0.025% Dutasteride solution application every 2 weeks. Total of 3ml of solution will be applied over the entire area of hairloss, including the frontal hairline, and vertex. The total durati

Topical 0.025% Dutasteride solution application every 2 weeks. Total of 3ml of solution will be applied over the entire area of hairloss, including the frontal hairline, and vertex. The total duration of the intervention is 24 weeks. The application each time will be carried out in the clinic. There are no additional strategies to monitor adherence since it will be applied in the clinic.

Locations(1)

NSW, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12626000082303